+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomarkers in Gastrointestinal Disease, An Issue of Gastroenterology Clinics of North America. The Clinics: Internal Medicine Volume 55-1

  • Book

  • February 2026
  • Region: North America
  • Elsevier Health Science
  • ID: 6252422
In this issue of Gastroenterology Clinics, guest editor Dr. Ashwin N. Ananthakrishnan brings his considerable expertise to the topic of Biomarkers in Gastrointestinal Disease. The field of gastroenterology is increasingly moving towards a precision medicine approach for many diseases, personalizing diagnostic and therapeutic interventions to individual patient characteristics. Non-invasive biomarkers are an important tool to aid in such stratification. In this issue, top international experts bring the state of the art of such biomarkers for various gastrointestinal diseases to the practicing clinician.- Contains 13 relevant, practice-oriented topics, including diagnostic and prognostic biomarkers for Barrett's esophagus; celiac disease: conventional and novel biomarkers; biomarkers for disease activity in IBD; biomarkers for early detection and monitoring of colon cancer; gut microbial biomarkers for health; and more- Provides in-depth clinical reviews on biomarkers in gastrointestinal disease, offering actionable insights for clinical practice- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Diagnostic and Prognostic Biomarkers for Barrett’s Esophagus
Clinical Utility of Biomarkers for Barrett’s Esophagus: Guidelines and Future Directions
Emerging Tissue and Blood Biomarkers for Eosinophilic Esophagitis
Biomarkers for Gastric Cancer and Premalignant Gastric Conditions
Celiac Disease: Conventional and Novel Biomarkers
Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use
Biomarkers for Disease Activity in Inflammatory Bowel Disease
Biomarkers for Malignant and Nonmalignant Diseases of the Pancreas
Biomarkers for Early Detection and Monitoring of Colorectal Cancer
The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease
Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease
Biomarkers for the Diagnosis of Cirrhosis and Cirrhosis-Related Complications

Authors

Ashwin N. Ananthakrishnan Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School, USA.